
MarkMonitor sees 23% growth in offshore business exchanges for bulk pharmaceuticals and APIs

MarkMonitor sees 23% growth in offshore business exchanges for bulk pharmaceuticals and APIs

As more temperature-sensitive product move around the globe, industry and regulators intensify their efforts to improve packaging and manage safe shipping

FDA denies use of ‘calendarizing’ features when added to an ANDA

GSK worked with Kenco Logistic Services for a coordinated launch

A potential savings of $46 billion in working capital is available to the industry, says Accenture study

Annual survey rank public companies by environmental, social criteria

Industry woes go beyond current global economic downturn

Pharma industry involvement in the supply-chain transaction service remains low

Annual compilation tracks evolution of wholesaler services, adoption of new technologies

Tried-and-true consumer-marketing techniques help product launches, patient adherence programs

‘Managed Market Delegates on Demand’ is one; ‘Ask IMS’ is another; meanwhile, online communities offer on-demand access

With sales of human pharmaceuticals languishing, several factors are focusing increased attention on animal health products, once a little-noticed industry niche market

Program seeks to improve the economics of care for low-income families; more sites to come

Usually associated with manufacturing or laboratory processes, quality systems can improve post-marketing compliance efforts

Nearly 30% of acquiring companies do not evaluate FCPA risks prior to an acquisition

While nurses move into a more central role in prescribing and administering pharmaceuticals, the nursing professions debate industry influence

TAKE Supply Chain helps Three Rivers Pharmaceuticals organize its distribution and shipping operations

New technologies are creating a powerful link between patients and healthcare providers. This Connected Health World has implications for pharmaceutical business practices

Aggressive cost competition and the continuing growth of generic substitution will separate retailers’ interests from manufacturers’

The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one

FDA counters that the PMC program balances drug efficacy study with patient need

Annual surveys rank public companies by environmental, social criteria

Suspicious Order Monitoring (SOMLink) tracks ordering history with statistical analysis of baseline activity


The desire to compare drugs’ efficacy is shifting from a purely medical decision to a financial one

Globaltrackandtrace.org will try to build industry consensus on pharma security, traceability

European Court of Justice affirms a lower-court decision in a case dating to 1998

Though stem cells and other regenerative medicine techniques hold enormous promise, they also face an equally large set of obstacles, ranging from research funding to reimbursement

Under the theme of personalized medicine, in vitro diagnostics will play an increasingly important role in new drug entries and new therapies

Better internal collaboration within companies is critical to improving the vital physician-rep relationship